A New blaVIM Gene in a Pseudomonas putida Isolated from ENT Units in Sulaimani Hospitals

A total of twenty tensile biopsies were collected from children undergoing tonsillectomy from teaching hospital ENT department and Kurdistan private hospital in sulaimani city. All biopsies were homogenized and cultured; the obtained bacterial isolates were purified and identified by biochemical tests and VITEK 2 compact system. Among the twenty studied samples, only one Pseudomonas putida with probability of 99% was isolated. Antimicrobial susceptibility was carried out by disk diffusion method, Pseudomonas putida showed resistance to all antibiotics used except vancomycin. The isolate further subjected to PCR and DNA sequence analysis of blaVIM gene using different set of primers for different regions of VIM gene. The results were found to be PCR positive for the blaVIM gene. To determine the sequence of blaVIM gene, DNA sequencing performed. Sequence alignment of blaVIM gene with previously recorded blaVIM gene in NCBI- database showed that P. putida isolate have different blaVIM gene.

Authors:

• Dalanya Asaad Mohammed
• Dara Abdul Razaq

Keywords:

• Clinical isolates
• Putida
• Sulaimani
• Vim gene.

References:

[1] Allen, L. H., Herman, G.T. and Friedman, F.H. (2002). Staphylococcus
aureus Infection and Disease. Kluwer Academic Publishers. New York,
Boston, Dordrecht, London, Moscow.
[2] Dervisoglue, E., Dundar, D.O., Yegenaga, I., Willke, A.( 2007)
Peritonitis due to Pseudomonas putida in a Patient Receiving Automated
Peritoneal Dialysis". Infection.
[3] Jeong, S. H., Lee, K., Chong, Y. et al. (2003). Characterization of a new
integron containing VIM-2, a metallo-ß-lactamase gene cassette, in a
clinical isolate of Enterobacter cloacae. Journal of Antimicrobial
Chemotherapy 51, 397-400.
[4] Koh,T.H., Wang,G.C. and Sng,L.H.2004 IMP-1 and a novel metallobeta-
lactamase, VIM-6, in fluorescent pseudomonads isolated in
Singapore
[5] Lawrence, M. and Tierniy, J. (1999). Medical diagnosis and treatment.
38th Ed. California. San Francisco. California. USA.
[6] Lee K., Jong Back Lim, Jong Hwa Yum, 2002 blaVIM-2 Cassette-
Containing Novel Integrons in Metallo-β-Lactamase-Producing
Pseudomonas aeruginosa and Pseudomonas putida Isolates
Disseminated in a Korean Hospital, Antimicrob Agents Chemother.
April; 46(4): 1053-1058.
[7] Luzzaro, F., Docquier, J. D., Colinon, C. et al. (2004). Emergence in
Klebsiella pneumoniae and Enterobacter cloacae clinical isolates of the
VIM-4 metallo-ß-lactamase encoded by a conjugative plasmid.
Antimicrobial Agents and Chemotherapy 48, 648-50.
[8] Otenio, M.H., Da Silva, M.T.L., Marques, M.L.O, Roseiro, J.C., Bidoia,
E.D. (2005) "Benzene, Toluene, and Xylene Biodegradation by
Pseudomonas putida CCMI 852". Brazilian Journal of Microbiology. P.
258-261.
[9] Patzer,J.A., Walsh,T.R., Weeks,J., Dzierzanowska,D. and Toleman,M.A.
2009. Emergence and persistence of integron structures harbouring VIM
genes in the Children's Memorial Health Institute, Warsaw, Poland,
Antimicrob. Chemother. 63 (2), 269-273.
[10] Poirel L, Naas T, Nicolas D, Collet L, Bellais S, Cavallo J D, Nordmann
P. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-β-
lactamase and its plasmid- and integron-borne gene from a Pseudomonas
aeruginosa clinical isolate in France. Antimicrob Agents Chemother.
2000;44:891-897.
[11] Poirel, K. Ludovic Cabanne, Louis Collet, and Patrice
Nordmann(2006)Class II Transposon-Borne Structure Harboring
Metallo-_-Lactamase ,Gene blaVIM-2 in Pseudomonas
putida.Antimicrobial Agents And Chemotherapy, p. 2889-2891.
[12] Papadopoulou,C., Thisiadou,K., Sofianou,D. and
Siarkou,V.I.2007.blaVIM-1 metallo-beta-lactamase gene in
Pseudomonas putida clinical isolates. J of microbiology and infectious
disease,vol 4, 118.
[13] Rasmussen, B. A., Bush, K., Keeney, D. et al. (1996). Characterization
of IMI-1 ß-lactamase, a class A carbapenem-hydrolyzing enzyme from
Enterobacter cloacae. Antimicrobial Agents and Chemotherapy 40,
2080-6.
[14] Riccio M L, Franceschini N, Boschi L, Caravelli B, Cornaglia G,
Fontana R, Amicosante G, Rossolini G M.(2000) Characterization of the
metallo-β-lactamase determinant of Acinetobacter baumannii AC-54/97
reveals the existence of blaIMP allelic variants carried by gene cassettes
of different phylogeny. Antimicrob Agents Chemother;44:1229-1235
[15] Sachie Yomoda, Toyoji Okubo, Ayako Takahashi, Masami Murakami,
and Shizuko Iyobe(2003) Presence of Pseudomonas putida Strains
Harboring Plasmids Bearing the Metallo-_-Lactamase Gene blaIMP in a
Hospital in Japan ,Journal Of Clinical Microbiology, p. 4246-4251
[16] Santos,C., Caetano,T., Ferreira,S. and Mendo,S. 2008. J. Biology,
University of Aveiro, Campus Santiago, Aveiro 3810, Portugal
[17] Siarkou,V.I., Papadopoulou,C., Thisiadou,K. and Sofianou,2007.
JOURNAL Submitted Laboratory of Microbiology and Infectious
Diseases, Faculty of Veterinary Medicine, Aristotle University of
Thessaloniki, University Campus, Thessaloniki 54124, Greece
[18] Yan, J. J., Ko, W. W., Chuang, C. L. et al. (2005). Metallo-ß-lactamaseproducing
Enterobacteriaceae isolates in a university hospital in Taiwan:
prevalence of IMP-8 in Enterobacter cloacae and first identification of
VIM-2 in Citrobacter freundii. Journal of Antimicrobial Chemotherapy
50, 503-11.
[19] Yum,J.H., Choi,Y., Park,D.-Y., Yong,D., Lee,K. and
hong,Y.2005.Department of Laboratory Medicine and Research Institute
of Bacterial Resistance, Yonsei University College of Medicine, 134
Shinchondong, Seodaemungu, Seoul 120-752,Korea.